Molecular Oncology · 2013 · 10 citations · 19 references
MedicineCancer BiologyOncologyMolecular OncologyPrecision OncologyTumor MicroenvironmentCancer ImmunotherapyPatient StratificationPersonalized Cancer TherapyPersonalized ImmunotherapyPersonalized Treatment PlanningTargeted TherapyIndividualized TherapyIndividualized Treatment RegimensPersonalized Cancer Treatment
Abstract At the 17th International Symposium in the annual series of prestigious meetings organized by the Fritz Bender Foundation, 07–09 November 2013, researchers, clinicians and students gathered to discuss and exchange knowledge on individualized cancer therapies. Co‐organized and hosted by the Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain, the sessions covered genetic profiling of patients, tumor characterization, tumor–host relationships and therapeutic targets, with talks from many international experts in the field. The presentations summarized in this report illustrate the current status of our knowledge and the future directions for cancer research in these broad topic areas.
19
The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups
Christina Curtis, Sohrab P. Shah, Suet‐Feung Chin et al. · Nature · 2012 · 6.4K citations · Full text
Life Sciences, Genetics, Oncology +14
Highly Recurrent <i>TERT</i> Promoter Mutations in Human Melanoma
Franklin W. Huang, Eran Hodis, Mary Jue Xu et al. · Science · 2013 · 1.8K citations · Full text
Large-scale genotyping identifies 41 new loci associated with breast cancer risk
Kyriaki Michailidou, Per Hall, Anna González‐Neira et al. · Nature Genetics · 2013 · 1.1K citations · Full text
The Genetic Landscape of Clinical Resistance to RAF Inhibition in Metastatic Melanoma
Eliezer M. Van Allen, Nikhil Wagle, Antje Sucker et al. · Cancer Discovery · 2013 · 940 citations · Full text
Role of Macrophage Targeting in the Antitumor Activity of Trabectedin
Giovanni Germano, Roberta Frapolli, Cristina Belgiovine et al. · Cancer Cell · 2013 · 862 citations · Full text
Life Sciences, Immunology, Oncology +14